Skip to content
Pharma Observatory a Scientist.com platform

Forecasts and asset valuation

Pharma Observatory and Evaluate

Evaluate (sub-brands Omnium, Epi, Biomedtracker) sells consensus analyst forecasts, market sizing and asset-valuation data. Pharma Observatory resolves trials, sites, investigators, companies and investors into one connected model whose record pages link figures to their source records.

Individual plan, $249/seat/mo. Card required.

What Evaluate is

Evaluate's data-feeds page describes consensus analyst forecasts and asset-valuation data, which can be delivered through Snowflake and flat files, with selected APIs also available across the wider portfolio. source

Its pricing page is quote-only: it invites visitors to "Get tailored pricing" and "Submit an RFP". source

What Pharma Observatory is

Pharma Observatory is a connected model of public biomedical evidence. Trials, drugs, companies, people and sites are each matched into one record, and figures on record pages link to their source records. It holds 94+ data sources, 930 million+ source records, 600,000+ trials, 380,000+ investigators, 1 million+ research sites, 350,000+ organizations, 790,000+ publications (rounded down to two significant figures; each is defined on the data page). Public trial data comes from ClinicalTrials.gov.

A company page carries financial figures reported in its SEC filings: public float, revenue, net income, R&D spend and total assets, beside ownership and 13F holders. These are reported figures, not analyst forecasts.

A company financial page: public float, shares outstanding, revenue, net income, R&D spend and total assets, with a note on the SEC source
A company's Financial & Ownership page, with figures drawn from its SEC filings. Captured from production data on 2026-10-08.

Side by side

Every Evaluate value is quoted or summarized from its own pages, with the page linked and the date we checked it. Ours comes from this application; the counts and the date they were taken are on the data page.

Pharma Observatory compared with Evaluate
Fact Pharma Observatory Evaluate
Published pricing Individual $249/seat/mo; Team $399/seat/mo; Enterprise sales-led verify Quote-only: "Get tailored pricing", "Submit an RFP"source
Self-serve sign-up Individual and Team self-serve checkout verify Nosource
Trial 14-day trial on Individual (Card required. Your first charge is when the trial ends) verify Nosource
Works inside an AI agent Included in every paid plan. We issue your connector credential after sign-up; setup steps are published for Claude Code, Claude Desktop, ChatGPT, Codex CLI, and Cursor Whether connections are open is read live from this deployment's identity provider configuration verify Not published
REST API Enterprise plan; documented in the OpenAPI specification verify Not published
Data sources 94+ data sources, 930 million+ source records, 600,000+ trials, 380,000+ investigators, 1 million+ research sites, 350,000+ organizations, 790,000+ publications Rounded down to two significant figures, defined on the data page verify Consensus analyst forecasts and asset-valuation data, which can be delivered through Snowflake and flat files, with selected APIs also available across the wider portfoliosource
Connected entity model One resolved identity per trial, drug, company, person and site verify Not published
Update cadence Rebuilt each cycle verify Not published
Citations Figures on record pages link to their source records verify Not published

Pharma Observatory

Published pricing
Individual $249/seat/mo; Team $399/seat/mo; Enterprise sales-led verify
Self-serve sign-up
Individual and Team self-serve checkout verify
Trial
14-day trial on Individual (Card required. Your first charge is when the trial ends) verify
Works inside an AI agent
Included in every paid plan. We issue your connector credential after sign-up; setup steps are published for Claude Code, Claude Desktop, ChatGPT, Codex CLI, and Cursor Whether connections are open is read live from this deployment's identity provider configuration verify
REST API
Enterprise plan; documented in the OpenAPI specification verify
Data sources
94+ data sources, 930 million+ source records, 600,000+ trials, 380,000+ investigators, 1 million+ research sites, 350,000+ organizations, 790,000+ publications Rounded down to two significant figures, defined on the data page verify
Connected entity model
One resolved identity per trial, drug, company, person and site verify
Update cadence
Rebuilt each cycle verify
Citations
Figures on record pages link to their source records verify

Evaluate

Published pricing
Quote-only: "Get tailored pricing", "Submit an RFP"source
Self-serve sign-up
Nosource
Trial
Nosource
Works inside an AI agent
Not published
REST API
Not published
Data sources
Consensus analyst forecasts and asset-valuation data, which can be delivered through Snowflake and flat files, with selected APIs also available across the wider portfoliosource
Connected entity model
Not published
Update cadence
Not published
Citations
Not published

Scope: A published price here is not like-for-like coverage: the two products cover different things, as the summary at the top of the page says.

Which to choose

Choose Evaluate when

  • You need consensus analyst forecasts and asset-valuation data delivered through Snowflake or flat files across a wider commercial-intelligence portfolio. source

Choose Pharma Observatory when

  • You want to see the price before talking to anyone. Individual $249/seat/mo; Team $399/seat/mo; Enterprise sales-led.
  • You want to start on a card. 14-day trial on Individual (Card required. Your first charge is when the trial ends).
  • You want one connected record, with links from figures to their source records. One resolved identity per trial, drug, company, person and site.
  • You want to put an AI assistant on the same data. Included in every paid plan. We issue your connector credential after sign-up; setup steps are published for Claude Code, Claude Desktop, ChatGPT, Codex CLI, and Cursor.

Sources

Every Evaluate statement above, from Evaluate's own pages.

We publish this comparison and are one of the products discussed.

Every fact here is re-checked at least every 90 days; the newest check was 2026-10-09 (4 days ago).

Browse the index

Other names are trademarks of their respective owners; no affiliation or endorsement is implied.